A Novel Approach to Plantar Fasciitis in the Aging Population The NAPA trial
A Novel Approach to Plantar Fasciitis in the Aging Population The NAPA trial
批准号:
10367293
负责人:
IRENE S DAVIS
金额:
$77.31万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2025-05-31
关键词:
AdultAgeAgingAtrophicChronicCumulative Trauma DisordersDrug PrescriptionsElderlyEquilibriumExerciseExhibitsFoot PainGoalsIncidenceIndividualInterventionKneeKnee OsteoarthritisLaboratoriesLeadMeasuresMental DepressionMethodsMonitorMuscleMuscle WeaknessMuscular AtrophyOlder PopulationOrthotic DevicesOutcomeOutcome MeasurePainParticipantPatientsPhysical FunctionPlantar FasciitisPlantar fascia structurePopulationQuality of lifeQuestionnairesRandomizedRecurrenceResearchResolutionRiskShoesSiteStretchingSymptomsTestingTimeTrainingWalkingaging populationbasecomparison interventiondesignexperienceflexibilityfollow-upfootfunctional outcomesimprovedimproved outcomemuscle strengthnovelnovel strategiesprogramsrecruitstandard of careultrasoundwalking speed
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Plantar fasciitis, a repetitive strain injury, is one of the most common causes of foot pain. Ten percent of aging
adults experience plantar fasciitis with 50% of the cases being disabling. Foot pain can lead to other problems
such as reduced mobility, depression and prescription medication use, leading to a reduced quality of life.
Relationships have been established between foot pain and weakness, reduced static and dynamic balance,
and reduced walking speed in aging adults. The standard of care for plantar fasciitis is to brace the foot with
foot orthoses and supportive shoes. However, chronic support of the arch has been shown to lead to intrinsic
foot muscle atrophy. As plantar fasciitis is associated with this atrophy, treating it with chronic arch support
only increases the risk for recurrence. In fact, there is a 50% recurrence rate and a 45.6% risk of having
plantar fasciitis 10 years after the onset of symptoms in older adults.
Minimal shoes are designed to allow the foot to function naturally, as if barefoot. They have already been
successfully implemented in older adults for the treatment of knee osteoarthritis. Minimal shoes are highly
flexible and lack the support of conventional footwear. This places greater demand on the foot muscles which
promotes strengthening. Stronger foot intrinsic foot muscles have been shown to reduce the strain on the
plantar fascia with each step, thereby reducing the risk of developing plantar fasciitis.
Long-term Goal: To improve treatment interventions for plantar fasciitis in aging adults.
Specific Aims: 1. Compare pain and physical function between the minimal footwear (MF) and the foot orthotic
(FO) groups at the 3 and 6 month follow-up, 2. Compare changes in intrinsic foot muscle size and strength
between MF and FO groups at the 3 and 6 month follow-up, and 3. Compare the incidence of recurrence of
plantar fascial pain between the MF and FO groups at the 12 month follow-up
Methods: 120 participants with plantar fasciitis (>6 mos.) will be recruited from 2 sites. They will be
randomized into a minimal footwear (MF) and foot orthotic (FO) group. Baseline measures of foot muscle size
and strength, static and dynamic balance, 6 min. walk test and two functional outcome questionnaires will be
obtained. The MF group will receive 2 pair of minimal shoes, and the FO group will receive 2 pair of supportive
shoes and prefabricated foot orthoses. The MF group will be given a 4-week program of foot strengthening
and flexibility exercises, while the FO group will only receive the flexibility exercises. Both groups will be given
an 8-week footwear transition program based upon their individual baseline step counts. They will return to the
laboratory to repeat the baseline measures at 3 and 6 mos. Plantar fascial pain and daily step counts will be
monitored over the course of the year. Comparisons in outcome measures as well as plantar fasciitis
recurrence will be compared between the groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Approach to Plantar Fasciitis in the Aging Population The NAPA trial
-
批准号:10689012
-
项目类别:
-
资助金额:$52.68万
-
财政年份:2022
-
负责人:IRENE S DAVIS
-
依托单位:
NIH-BIOMECHANICS IN MOVEMENT SCIENCE: BUILDING TRANSDOMAIN BRIDGES
-
批准号:7805092
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2010
-
负责人:IRENE S DAVIS
-
依托单位:
Real-time Gait Retraining to Reduce Loading in Runners
-
批准号:7262652
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2007
-
负责人:IRENE S DAVIS
-
依托单位:
Real-time Gait Retraining to Reduce Loading in Runners
-
批准号:7429765
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2007
-
负责人:IRENE S DAVIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: